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Abstract
Trefoil factor family (TFF) peptides are typical secretory products of mucin-producing cells, e.g. of the gastrointestinal
tract. Here, the expression and secretion of mucins and TFF peptides was studied in the HT-29 cell line throughout cellular
growth and differentiation in relation to a mucin-secreting (HT-29 MTX) or an enterocyte-like (HT-29 G3) phenotype.
mRNAs of several MUC and TFF genes were expressed in both cell subpopulations. However, for most MUC and TFF
genes, the expression appeared strongly induced with the differentiation into the mucin-secreting phenotype. On the other
hand, TFF2 was specifically expressed in the mucin-secreting HT-29 MTX cells. The differentiation of HT-29 MTX cells into
the mucin-secreting phenotype was characterised by secretion of the gel-forming mucins MUC2, MUC5AC, and MUC5B,
however, according to a different pattern in the course of differentiation. A significant amount of TFF1 and TFF3 was
secreted after differentiation, also according to a different pattern, whereas TFF2 was only faintly detected. Secretagogues,
known to induce the secretion of mucus, increased the secretion of all three TFF peptides. In contrast, neither a secretory
mucin nor a TFF peptide was found in the culture medium of HT-29 G3 cells. Overlay assays indicated that HT-29 MTX
mucins bound to secretory peptides of HT-29 MTX cells with relative molecular mass similar to TFF peptides. TFF1 and
TFF3 were specifically localised in the mucus layer of HT-29 MTX cells by confocal microscopy. Finally, the secretion of
TFF peptides and mucins appears as a co-ordinated process which only occurs after differentiation into goblet cell-like
phenotype. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
TFF peptides (trefoil factor family peptides) [1] are
typically secreted by mucin-producing epithelia [2^6].
Three TFF peptides are known in man: TFF1 (for-
merly pS2), TFF2 (formerly hSP) and TFF3 (for-
merly hP1.B/hITF). The expression patterns of
TFF peptides vary characteristically: TFF1 is found
in the stomach, TFF2 in the stomach and biliary tree
and TFF3 throughout the small and large intestine
[5]. Expression of TFF peptides has also been studied
in the respiratory tract [7], the conjunctiva [8], the
salivary glands [9] and uterus [10]. Mucins are a het-
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erogeneous family of O-linked glycoproteins encoded
by di¡erent human mucin genes (MUC genes). To
date, 11 MUC genes have been identi¢ed (MUC1 to
MUC8) [11,12], MUC11 and MUC12 [13]. The
MUC genes also display a site-speci¢c distribution
in the gastrointestinal tract: MUC5AC and MUC6
are respectively produced by the surface and glan-
dular epithelia of gastric mucosa, whereas MUC2
and MUC3 are found in the small and large intestine
[11,12]. TFF peptides form characteristic constituents
of mucus gels protecting various delicate epithelia of
vertebrates. TFF domains also form integral parts of
frog integumentary mucins FIM-A.1 [14,15] and
FIM-C.1 [16]. This led to the hypothesis that TFF
peptides may act by linking mucins and may thereby
in£uence the rheological properties of the mucus
[17,18]. Preliminary studies seem to con¢rm this hy-
pothesis; for example, TFF2 and TFF3 have been
reported to increase the viscosity of mucin prepara-
tions [3] and TFF3 protected a T84 cell line from a
toxic lectin by co-operative interaction with mucin
[19]. Recently, using the two-hybrid system, murine
TFF1 was shown to interact with the von Willebrand
factor C cysteine-rich domains of murine MUC2 and
MUC5AC mucins [20]. All three TFF peptides also
act as motogens modulating the migration of a vari-
ety of cell lines in wound healing assays [21^23].
Derivatives of the colon carcinoma HT-29 cell line
were investigated in order to study the secretion of
TFF peptides and mucins in vitro. HT-29 cultures
are heterogeneous and consist to s 95% of undi¡er-
entiated cells, with a small proportion of di¡erenti-
ated mucus-secreting or columnar absorptive cells in
the postcon£uent state [24^26]. Di¡erentiated popu-
lations of either absorptive or mucin-secreting cells
can be obtained after selection via drug treatment or
hexose deprivation. At 1035 M methotrexate, a ho-
mogeneous subpopulation of mucin-secreting cells
(HT-29 MTX), showing a goblet cell-like phenotype
with numerous mucous vacuoles, was obtained
[26,27]. These cells express several membrane and
secretory MUC genes; however, the MUC5AC
gene, a gene normally expressed in the stomach, ac-
counts for the major expressed MUC gene in this cell
subpopulation [28^31]. Furthermore, HT-29 MTX
cells synthesise sialylated mucins sharing epitopes
with normal gastric mucins [27,32]. The oligosaccha-
rides of HT-29 MTX mucins consist of short sialyl-
ated structures, mainly of core types 1 and 2 [31].
Secretion of mucus, and particularly of the MU-
C5AC mucin, by postcon£uent HT-29 MTX cells
can be stimulated by the calcium ionophore
A23187 combined either with PMA or with forskolin
[31]. In contrast, glucose deprivation of HT-29 cells
led to the selection of a subpopulation of di¡erenti-
ated enterocyte-like cells (HT-29 G3) [33]. Previous
work reported that di¡erent HT-29 clones exhibiting
a goblet cell phenotype such as HT-29N2 and HT-
29H2 express TFF3, whereas in the enterocyte-like
HT-29C18 cells, synthesis of TFF3 is reduced
[34,35]. Secretion of TFF3 by HT-29 cells has been
reported in the past to be stimulated for example by
carbachol [36]. Beck et al. [37] have shown recently
that the expression of the three TFF genes is altered
in parental HT-29 cells in relation to cell growth.
These previous data raised the question of the com-
plementary nature of TFF peptides and mucins and
led us to undertake a study of TFF peptides in rela-
tion to mucins using the mucin-secreting HT-29
MTX cells versus the non mucin-secreting HT-29
G3 cells.
2. Materials and methods
2.1. Cell culture
Parental HT-29 cells (referred to as HT-29 STD)
selected by adaptation to 1035 M methotrexate (re-
ferred to as HT-29 MTX) and HT-29 cells adapted
to glucose deprivation (referred to as HT-29 G3)
have been described [26,31]. These selected cell lines
were subsequently grown in standard Dulbecco’s
modi¢ed Eagle’s minimal essential medium (Eurobio,
Paris, France), supplemented with 10% (v/v) heat-in-
activated foetal calf serum. Cells were seeded at
2U104 cells/cm2 and cultured at 37‡C in a 10%
CO2/90% air atmosphere. The medium was changed
daily. The cells were cultivated in a serum-free me-
dium containing 0.01% bovine serum albumin for
24 h before collection of conditioned medium.
A stimulation of mucin-secreting HT-29 MTX
cells was carried out by two combinations of secre-
tagogues. The cells were stimulated for 45 min with
calcium ionophore A23187 4U1035 M combined ei-
ther with phorbol 12-myristate 13-acetate (PMA)
BBAMCR 14750 21-5-01
V. Gouyer et al. / Biochimica et Biophysica Acta 1539 (2001) 71^8472
25 WM or with forskolin 1034 M. PMA, forskolin
and calcium ionophore A23187 were provided by
Sigma (France).
2.2. RT-PCR analysis
Total RNA was isolated from HT-29 cells at dif-
ferent times throughout growth and di¡erentiation
(from day 4 up to day 21) by ultracentrifugation
through a cesium chloride cushion [30].
RT-PCR analysis was performed for the ampli¢-
cation of the mucin mRNAs with speci¢c primers for
MUC1, MUC2, MUC3, MUC4, MUC5AC,
MUC5B, MUC6, MUC7, MUC11 and MUC12. In
order to be sure of the absence of contamination by
genomic DNA, and also to ensure to speci¢city of
the ampli¢cation to each MUC gene, the primers
were located at the junction of the next to last
exon and the last exon and in the 3P untranslated
region extremity.
Primers: MUC1 forward primer: 5P-GAAC-
TACGGGCAGCTGGACATC-3P, MUC1 reverse
primer: 5P-GCTCTCTGGGCCAGTCCTCCTG-3P
(position nucleotides (nt) 3640^3661 and nt 4065^
4086, accession No. J05582 [38]); MUC2 forward
primer: 5P-CTGCACCAAGACCGTCCTCATG-3P,
MUC2 reverse primer: 5P-GCAAGGACTGAA-
CAAAGACTCAGAC-3P (position nt 15291^15312
and nt 15667^15691, accession No. L21998 [39]);
MUC3 forward primer: 5P-AGTCCACGTTGAC-
CACTGC-3P, MUC3 reverse primer: 5P-TGTTCA-
CATCCTGGCTGGCG-3P (position nt 2526^2547
and nt 2912^2931, accession No. AF007194 [40];
MUC4 forward primer: 5P-CGCGGTGGTGGAG-
GCGTTCTT-3P, MUC4 reverse primer: 5P-GAA-
GAATCCTGACAGCCTTCA-3P (position nt 2994^
3014 and nt 3569^3589, accession No. AJ010901
[41]); MUC5AC forward primer: 5P-TGATCATC-
CAGCAGCAGGGCT-3P, MUC5AC reverse prim-
er: 5P-CCGAGCTCAGAGGACATATGGG-3P (po-
sition nt 2897^2917 and nt 3284^3305, accession No.
AJ001402 [42]); MUC5B forward primer: 5P-CTGC-
GAGACCGAGGTCAACATC-3P, MUC5B reverse
primer: 5P-TGGGCAGCAGGAGCACGGAG-3P
(position nt 9057^9078 and nt 10108^10127, acces-
sion No. Y09788 [43]); MUC6 forward primer: 5P-
GCATGGCGAACGTGACGGTAA-3P, MUC6 re-
verse primer: 5P-TAGTCTGAGCCCCTGCTTGG-
CA-3P (position nt 1034^1054 and nt 1433^1454,
accession No. U97698 [44]); MUC7 froward prim-
er: 5P-CCACACCTAATTCTTCCCCAACTAC-3P,
MUC7 reverse primer: 5P-CTGGCTTGTGGGATA-
GAGGCATT-3P (position nt 1022^1046 and nt
1406^1428, accession No. L13283 [45]); MUC11 for-
ward primer: 5P-CAGGCGTCAGTCAGGAATC-
TACAG-3P, MUC11 reverse primer: 5P-GAGGCT-
GTGGTGTTGTCAGGTAAG-3P (position nt 47^70
and nt 192^215, accession No. AF147791 [13]);
MUC12 forward primer: 5P-TGAAGGGCGACAA-
TCTTCCTC-3P, MUC12 reverse primer: 5P-TAC-
ACGAGGCTCTTGGCGATGTTG-3P (position nt
972^952 and nt 1439^1462, accession No.
AF147790 [13]).
Glyceraldehyde-3-phosphate dehydrogenase (GA-
PDH) was ampli¢ed as internal control (G3PDH
Control Amplimer Set, Clontech).
RT-PCR analysis monitoring expression of TFF1,
TFF2 or TFF3 was performed as described by Beck
et al. [37] using 30 ampli¢cation cycles.
2.3. Antibodies and Western blot analysis
The rabbit polyclonal anti-mucin antibodies (anti-
MUC2, anti-MUC5B, and anti-MUC5AC) were a
gift from Dr. Carlstedt (Lund University, Sweden).
The anti-apomucin MUC2 (LUM2-3), anti-apo-
mucin MUC5AC (LUM5-1) and anti-apomucin
MUC5B antibodies (LUM5B-2) were respectively
raised against synthetic peptides present in the non-
glycosylated region of mucins with the sequence
NGLQPVRVEDPDGC [46], RNQDQQGPFKMC
[47] and RVNRVEQVKGFKMC [48].
Polyclonal rabbit antibody against human TFF1
was purchased from Novocastra (NCL-pS2). The
polyclonal rabbit antiserum anti-hTFF2-1 against
the C-terminus of human TFF2 was generated by
coupling the synthetic peptide FFPNSVEDCHY
(kindly provided by Dr. H. Kalbacher, Tu«bingen,
Germany) to keyhole limpet haemocyanin with glu-
taraldehyde and immunising a rabbit similarly as de-
scribed [49]. The polyclonal rabbit antiserum anti-
hTFF3-2 against the C-terminus of human TFF3
as well as its a⁄nity puri¢cation were described pre-
viously [7].
Centrifuged culture media, normalised to cellular
proteins, were analysed on 2^10% or 5^30% sodium
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dodecyl sulphate (SDS)^polyacrylamide gel under re-
ducing conditions for the characterisation of secreted
mucins and TFF peptides. After transfer to a Hy-
bond-C extra membrane (Amersham, Aylesbury,
UK), the membrane was treated with the anti-mucin
or anti-TFF antibody and then with the peroxidase-
conjugated anti-mouse or anti-rabbit antibody (Sig-
ma, St. Louis, MO, USA) diluted 4000-fold. Detec-
tion was carried out by luminescence using the ECL
Western blotting kit (Amersham).
The speci¢city of each anti-TFF antibody was
checked on positive controls (extracts of human
stomach or colon).
2.4. ELISA
Culture media from HT-29 MTX cells normalised
to cellular protein content were plated overnight at
4‡C on 96-well Maxisorp immunoplates. Unbound
sites were blocked with 4% (w/v) BSA in PBS. After
washing with PBS, anti-TFF antibodies diluted in
PBS/1% BSA were added and left for 1 h at 37‡C.
After washing once with PBS/0.1% Tween, and twice
with PBS, peroxidase-conjugated anti-mouse anti-
body was applied for 90 min at 37‡C. Plates were
washed and developed using o-phenylenediamine (1
mg/ml) in 0.1 M phosphate/citrate bu¡er, pH 5.5
with 0.015% (v/v) hydrogen peroxide. The reaction
was terminated with 1 M HCl and A490nm was mea-
sured. For the control cells and cells stimulated by
each combination of secretagogues ELISA assay was
carried out in triplicate.
2.5. Overlay experiment
2.5.1. SDS^polyacrylamide gel electrophoresis
(PAGE) and blotting of cell culture medium
Cells were cultured in standard conditions up to
day 20 and then in serum-free medium for 24 h. Cell
culture media (20 Wl) were submitted to SDS^PAGE
(5^30% gradient) according to the method of
Laemmli. Proteins were then transferred to nitrocel-
lulose (Amersham, Arlington Heights, IL, USA) with
a Multiphor II Novablot unit (Pharmacia LKB).
2.5.2. Preparation of HT-29 MTX mucins and
labelling
Isolation of mucins from HT-29 MTX cells was
obtained by CsBr density gradient centrifugation
[32]. Radioiodination of mucins was performed
with Iodo-beads (Pierce) and as previously described
[50]. Brie£y, 10 mg of HT-29 MTX mucins were
dissolved in 1 ml of phosphate bu¡er, and iodinated
with 750 WCi of 125I (Amersham) by the addition of
two Iodo-beads. Radiolabelled mucins were sepa-
rated from residual iodide by gel ¢ltration on Se-
pharose CL-4B.
2.5.3. Detection of mucin-binding proteins
The blots on nitrocellulose were ¢rst maintained in
PBS containing 2% BSA for 2 h under mild agita-
tion. The BSA solution was replaced by radiolabelled
mucins at a concentration of 100 Wg/ml in PBS con-
taining 1% BSA and the blots were left under mild
agitation for another 2 h at room temperature. The
blots were washed with PBS, then with 0.05% Tween
20 in PBS, dried on ¢lter paper, and then exposed at
370‡C to X-ray ¢lm to detect mucin binding to pro-
tein.
2.6. Confocal microscopy
Confocal microscopy was performed on cell mono-
layers cultured on polycarbonate ¢lters at day 14
after seeding. Cells were ¢xed with 4% paraformal-
dehyde and treated with 0.1% saponin in PBS for 20
min. After a saturation step for 30 min in PBS/1%
BSA, immunolabelling was carried out using a poly-
clonal anti-mucin or anti-TFF antibody (anti-MU-
C5AC (LUM5-1), anti-TFF1 (NCL-pS2), anti-
TFF2 (hTFF2-1) or anti-TFF3 (hTFF3-2) antibody).
Primary antibodies were incubated overnight (1/250
dilution for hTFF3-2, 1/250 dilution for LUM5-1
and 1/100 dilution for pS2 and for anti-hTFF2-1)
C
Fig. 1. RT-PCR analysis of MUC mRNAs. The expression of the di¡erent MUC genes was monitored in HT-29 MTX and HT-29
G3 cells at di¡erent time points during growth and di¡erentiation; given are the days after seeding the cells. The molecular size stan-
dard is shown on the left.
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in PBS/1% BSA, and labelled with goat anti-rabbit
FITC-conjugated secondary antibody (Jackson, Bal-
timore, MD, USA). Observations were made with a
Leica confocal microscope (Leica, TCS-NT).
3. Results
3.1. Expression of MUC and TFF genes throughout
the di¡erentiation process of HT-29 MTX and
HT-29 G3 cells
The expression of MUC (Fig. 1) and TFF (Fig. 2)
genes was comparatively studied in HT-29 subpopu-
lations committed to a di¡erentiation into the mucin-
secreting (HT-29 MTX) or the enterocyte-like (HT-
29 G3) phenotype. The appearance of MUC and
TFF transcripts was analysed by RT-PCR in the
course of the culture from a subcon£uent state (day
4) up to a late postcon£uent state (day 21).
MUC expression patterns in HT-29 MTX and
HT-29 G3 cells are shown in Fig. 1. MUC1,
MUC3, and MUC4 genes encoding membrane mu-
cins, MUC2, MUC5B and MUC5AC genes encoding
secretory mucins, as well as the recently cloned par-
tial cDNA sequence of MUC11 were expressed in
HT-29 MTX cells. Transcripts for all these genes
became expressed at di¡erent time points before con-
£uence: day 4 for MUC1, MUC3, MUC4 and MU-
C5AC, day 5 for MUC2 and MUC5B and day 7 for
Fig. 2. RT-PCR analysis of TFF mRNAs. TFF1, TFF2, or TFF3 expression was monitored in HT-29 MTX and HT-29 G3 cells at
di¡erent time points during growth and di¡erentiation; given are the days after seeding the cells. The molecular size standard is
shown on the left.
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MUC11. Their expression reached the maximal level
with the induction of cell di¡erentiation, and then
either decreased throughout late con£uence (for
MUC2 and MUC4), or remained at a similar level
(for MUC1, MUC3, MUC5AC, and MUC5B).
MUC6, MUC7 and MUC12 were not expressed,
and MUC11 was detected at a very low level. De-
spite the non-mucin-secreting phenotype of HT-29
G3 cells, several MUC genes were found expressed,
in particular MUC1 and MUC4 encoding mem-
brane-type mucins, and MUC2 and MUC5B encod-
ing gel-forming mucins. MUC11 transcripts were
found at a faint level throughout the cell culture.
TFF expression patterns in HT-29 MTX and HT-
29 G3 cells are shown in Fig. 2. TFF1 and TFF3
transcripts were detected as soon as day 5 in HT-29
Fig. 3. Western blot analysis of MUC proteins. SDS^PAGE (2^10% gradient) and subsequent Western blot analysis of 20 Wl of cul-
ture medium collected at various time points during growth and di¡erentiation of HT-29 MTX cells ; given are the days after seeding
the cells. The following polyclonal antisera against human mucins were used: anti-MUC5AC antibody (LUM5-1), anti-MUC5B anti-
body (LUM5B-2) and anti-MUC2 antibody (LUM2-3). The molecular weight standard is shown on the left.
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MTX, then markedly increased, and remained at a
similar level up to day 21. TFF2 was not detectable
before con£uence, and became apparent only starting
with day 11. In HT-29 G3 cells, TFF1 appeared at a
low level at late con£uence, TFF3 was faintly ex-
pressed at day 4, and increased thereafter, but
TFF2 was not at all detectable.
3.2. Secretion of mucins and TFF peptides throughout
the di¡erentiation process of HT-29 MTX and
HT-29 G3 cells
The culture media of HT-29 MTX and HT-29 G3
cells were analysed for the presence of the gel-form-
ing mucins MUC2, MUC5AC and MUC5B at di¡er-
ent time points throughout the di¡erentiation process
by Western blot. In HT-29 MTX cells (Fig. 3), the
mucin MUC5AC became secreted from day 9, and
then appeared as a strong band from day 13 up to
day 21 (Fig. 3). In contrast the other gel-forming
mucins were less detectable and displayed a limited
pattern of secretion: MUC2 could be clearly visual-
ised from day 9 up to day 15, while MUC5B became
mostly secreted at late con£uence, particularly from
day 17 up to day 19, and then markedly decreased.
In HT-29 G3 cells, MUC2, MUC5AC and MUC5B
were not detectable (data not illustrated).
The secretion of TFF1 and TFF3 by di¡erentiated
HT-29 MTX cells was clearly shown (Fig. 4). TFF1
became detectable in the culture medium starting
with day 11, increased from day 13 to day 15 and
appeared in the highest amount at late con£uence
(from day 17 up to day 21). TFF3 appeared earlier
in the extracellular culture media, i.e. from day 9,
and reached the highest level from day 13 up to
day 19. TFF2 was secreted at a very low level, being
only detected as a very faint band from day 17 to
day 19. No TFF peptides could be detectable in the
extracellular media of HT-29 G3 cells (data not il-
lustrated).
3.3. Secretion of TFF peptides by di¡erentiated
HT-29 MTX cells after stimulation by
secretagogues
The secretion of the TFF peptides was analysed by
ELISA after stimulation of postcon£uent HT-29
MTX cells with the calcium ionophore A23187
Fig. 4. Western blot analysis of TFF peptides. SDS^PAGE (5^30% gradient) and subsequent Western blot analysis of 20 Wl of culture
medium collected at various time points during di¡erentiation of HT-29 MTX cells ; given are the days after seeding the cells. The fol-
lowing polyclonal antisera against TFF peptides were used: anti-human TFF1 (NCL-pS2), a⁄nity puri¢ed anti-hTFF2-1 or a⁄nity
puri¢ed anti-hTFF3-2. The molecular weight standard is shown on the left.
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(4U1035 M) combined either with PMA (25 WM) or
with forskolin (1034 M) (Fig. 5). For each experi-
ment we have checked that the secretion of the mucin
MUC5AC was indeed stimulated as previously re-
ported [31]. Generally, the secretion of all three
TFF peptides was sensitive to secretagogue treat-
ments (Fig. 5). Extracellular TFF peptides were de-
tectable at signi¢cantly higher levels in comparison
to non-stimulated cells.
3.4. Detection of mucin-binding proteins
Proteins of the cell culture media from postcon£u-
ent di¡erentiated mucin-secreting (HT-29 MTX) or
undi¡erentiated (HT-29 STD) cells were separated by
PAGE before being transferred to a nitrocellulose
sheets and incubated with radiolabelled HT-29
MTX mucins. Three strong bands corresponding
to polypeptides with estimated relative molecular
masses between 7 kDa and 20 kDa were detected
in culture medium of postcon£uent HT-29 MTX
cells, whereas no labelling was observed with the
culture medium of undi¡erentiated HT-29 STD cells
(Fig. 6).
3.5. Localisation of TFF peptides by
confocal microscopy
HT-29 MTX cell monolayers at day 14 after seed-
ing cultured on ¢lter were analysed for labelling with
the polyclonal anti-TFF antibodies by confocal mi-
croscopy. The anti-MUC5AC antibody was used to
visualise the mucus layer, as MUC5AC was previ-
ously shown to account for the main mucin secreted
by HT-29 MTX cells [31].
The labelling obtained with the polyclonal anti-
MUC5AC antibody revealed that MUC5AC was
present in the majority of the cells, all over the apical
surface of the cells, in accordance with the presence
of mature mucins forming a viscous gel covering the
Fig. 5. Evaluation of the secretion of TFF peptides by ELISA. Culture medium was collected from control postcon£uent HT-29
MTX cells or from postcon£uent HT-29 MTX cells stimulated by PMA+Ca2 ionophore or by forskolin+Ca2 ionophore after 45
min incubation. The following polyclonal antisera against TFF peptides were used: anti-human TFF1 (NCL-pS2), a⁄nity puri¢ed
anti-hTFF2-1 or a⁄nity puri¢ed anti-hTFF3-2. Results represent the means of three determinations.
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cell monolayer (Fig. 7a). With the anti-TFF1 and
anti-TFF3 antibodies, only some cells were labelled,
and the labelling appeared as dense areas at the ap-
ical surface of the cells, corresponding to a localisa-
tion in the mucus layer (Fig. 7b,c). With the anti-
TFF2 antibody, the labelling was very low (data
not illustrated).
Monolayers of HT-29 G3 cells were labelled with
the anti-TFF antibodies and examined by confocal
microscopy. No labelling for TFF1, TFF2 or TFF3
could be detected (data not illustrated).
4. Discussion
A ¢rst aim in this work was to determine if the
mucin-secreting phenotype of HT-29 MTX cells was
associated to a speci¢c expression and secretion of
MUC and/or TFF genes. Thus, we compared these
two types of molecules at the mRNA and protein
levels in two di¡erent HT-29 cell populations, HT-
29 MTX and HT-29 G3 cells, committed to a di¡er-
entiation into the mucin-secreting or enterocytic phe-
notype, respectively. These cells acquire their di¡er-
entiation state after con£uence, i.e. day 7 after
seeding.
For most MUC genes, the mRNA expression ap-
peared strongly induced with the di¡erentiation into
the mucin-secreting phenotype: i.e. for MUC2,
MUC5B and MUC5AC genes encoding gel-forming
mucins, and for MUC3 and MUC4 genes encoding a
membrane-type mucin. However, we could observe
that the expression of MUC2 and MUC4 was overall
higher at the beginning of the di¡erentiation, and
then signi¢cantly decreased from day 11 or 13. The
expression of the three TFF peptides was also highly
induced with the di¡erentiation into the mucin-se-
creting phenotype. However, expression of some
MUC and TFF genes can be observed in HT-29
MTX cells well before the di¡erentiation state. For
example, MUC1, MUC2, MUC3, MUC4, MU-
C5AC and MUC5B as well as TFF1 and TFF3 tran-
scripts are already present before cells are con£uent,
i.e. at day 4 or 5 after seeding. Furthermore, all these
transcripts are also detectable in enterocyte-like HT-
29 G3 cells, indicating that expression of such genes
can be independent of a mucin-secreting phenotype.
Expression of TFF genes has also been reported in
the parental HT-29 cell line mainly consisting of un-
di¡erentiated cells [37], and TFF3 transcripts have
also been detected in HT-29/N2 cells before di¡er-
entiation into the goblet cell-like phenotype [33]. In
contrast, TFF2 transcripts appear in HT-29 MTX
cells at about day 11 and thereafter, and they never
appear in HT-29 G3 cells. Thus, the expression of
TFF2 in HT-29 MTX cells is speci¢cally upregulated
during di¡erentiation into the mucin-secreting phe-
notype.
The speci¢c expression of MUC and/or TFF pep-
tides in relation to the mucin-secreting phenotype of
HT-29 cells was further researched at the protein
level. All the expressed secretory mucins (MUC2,
MUC5B and MUC5AC) were found in the culture
medium of HT-29 MTX cells, however, according to
a di¡erent pattern of secretion. MUC5AC mucin ap-
peared to be the most steadily secreted starting from
Fig. 6. Overlay assay. Cell culture media collected from post-
con£uent HT-29 MTX and HT-29 STD cells were separated by
PAGE, transferred to nitrocellulose, incubated with radioiodi-
nated HT-29 MTX mucins and subjected to autoradiography.
HT-29 MTX mucins recognised peptides speci¢cally secreted by
HT-29 MTX cells.
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cell di¡erentiation, and has been reported previously
to be the predominant secretory mucin of this cell
population [31]. The secretion of other MUC genes
appeared fainter and limited to a shorter period dur-
ing the di¡erentiation process. MUC2 mucin ap-
peared secreted just after cell con£uence, in accor-
dance with the expression pattern observed by RT-
PCR. In contrast, the MUC5B mucin became mostly
secreted at late con£uence. Concerning TFF pep-
tides, the secretion of both TFF1 and TFF3 was
clearly detected, showing a typical pattern of induc-
tion from the di¡erentiation state of HT-29 MTX
cells. However, di¡erent secretion patterns were ob-
served for these two TFF peptides: the secretion of
TFF1 started in well di¡erentiated HT-29 MTX cells,
and reached an optimal level at late con£uence,
whereas the secretion of TFF3 started at the begin-
ning of the di¡erentiation process, and reached an
optimal level thereafter. The extracellular secretion
of mucins and TFF peptides did not occur in undif-
ferentiated HT-29 MTX cells before con£uence. In
addition, neither gel-forming mucin nor TFF peptide
could be evidenced in the cell culture media of HT-29
G3 cells, whatever the culture time. These results
indicated that the secretion of TFF peptides was
speci¢cally associated with the mucin-secreting phe-
notype of HT-29 cells. This is in line with previous
reports on TFF3 expression of HT-29 clones exhib-
iting a goblet cell-like phenotype (HT-29N2 and HT-
29H2) [34] and also with the in vivo situation where
intestinal goblet cells typically secrete TFF3 [17,34].
There is therefore a discrepancy between expres-
sion and secretion of mucins and TFF peptides in
HT-29 cells. HT-29 MTX cells express some MUC
Fig. 7. Cellular localisation of TFF peptides in HT-29 MTX cells. Confocal microscopy of postcon£uent HT-29 MTX cell monolayers
with anti-mucin and anti-TFF antibodies (magni¢cation U608). x,y sections are shown. The mucus layer was visualised with the anti-
MUC5AC antibody (a). TFF1 (b) and TFF3 (c) were immunolocalised within the mucus layer.
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and TFF genes well before the corresponding pro-
teins are secreted. MUC transcripts of gel-forming
mucins appear before con£uence (i.e. from day 4 to
day 5), but are detectable much later after con£uence
in the extracellular medium (i.e. from day 9 to day
11). This latent period might be relevant to the fur-
ther processing steps of mucin biosynthesis : dimer-
isation, glycosylation, multimerisation, and intracel-
lular storage in mucus vacuoles [51]. However, there
is also a delay between secretion and expression of
TFF peptides. TFF1 and TFF3 transcripts also ap-
pear before con£uence (i.e. from day 5), but TFF
peptides are only detected later after con£uence in
the extracellular medium (i.e. from day 9 to day
11). A similar paradoxical situation is also present
in HT-29 G3 cells which express MUC and TFF
genes but never secrete these molecules. Perhaps
these genes are expressed at a very low level in
HT-29 G3 cells, as in HT-29 MTX cells before dif-
ferentiation, and so the corresponding proteins
would be present at a too low level to be detected
in the extracellular medium by Western blot. Anoth-
er possibility is that expressed TFF peptides would
not be translated. On this line, human sublingual
glands also express TFF1 and TFF3 which is not
followed by translation of these mRNAs [9]. The
behaviour of TFF2 is somewhat di¡erent, as this
TFF is not at all expressed in HT-29 G3 cells, but
is speci¢cally expressed in HT-29 MTX, and TFF2
transcript appeared later in the course of HT-29
MTX culture (from day 11) in comparison to the
other TFF genes. However, the secretion of this
TFF peptide was hardly detectable in the culture
medium of postcon£uent HT-29 MTX cells, suggest-
ing also that TFF2 could be expressed at a low level
in these di¡erentiated mucin-secreting cells.
Finally, the secretion of TFF peptides and mucins
appears as a co-ordinated process which only occurs
after di¡erentiation into a goblet cell-like phenotype.
Furthermore, TFF peptides as mucins respond to
secretagogue stimulations. Indeed, a marked increase
in TFF peptide secretion was observed after com-
bined stimulation with Ca2 ionophore and PMA,
or Ca2 ionophore and forskolin. These two pairs
of associated secretagogues have been reported pre-
viously to increase the secretion of mucus and in
particular the MUC5AC mucin by HT-29 MTX cells
[31]. The question arises whether TFF peptides inter-
act with mucins in the formation of a complex vis-
cous mucus biopolymer as predicted in the past [16].
Recent work showed an interaction of murine TFF1
with murine MUC2 and MUC5AC mucins, via the
von Willebrand factor C cysteine-rich domains, using
a yeast two-hybrid system [20]. Thus, the interaction
between TFF peptides and secretory mucins could
occur independently of their tissue-speci¢c localisa-
tion, and could be a general characteristic between
these two types of molecules. Using an overlay ex-
periment with radiolabelled mucins from HT-29
MTX cells we could observe that peptides speci¢cally
secreted by the HT-29 MTX cells, and with molec-
ular weight similar to TFF peptides, were able to
bind strongly to the HT-29 MTX mucins. Data ob-
tained by confocal microscopy have shown that
TFF1 and TFF3 were localised in the mucus layer
covering the HT-29 MTX cells, suggesting that they
might play a role in the cohesion of the mucus gel. In
normal epithelia, MUC5AC and TFF1 are expressed
in the stomach, whereas MUC2 and TFF3 are ex-
pressed in the small and large intestine [5,11]. MU-
C5AC and MUC2 are both produced by HT-29
MTX cells, and the ¢nding of both TFF1 and
TFF3 in the mucus layer reinforces the hypothesis
that these TFF peptides might play a role in the
constitution of the mucus evolved from these mucins.
In conclusion, the secretion of gel-forming mucins
and TFF peptides is associated to the mucin-secret-
ing phenotype of HT-29 cells, although some of them
can be expressed at the mRNA level in non-mucin-
secreting HT-29 cells. The secretion patterns of these
molecules show di¡erences in the time of secretion
and the produced amount. However, there was con-
comitance between the appearance of a mucin and a
TFF peptide in the extracellular medium. Further-
more, TFF peptides were found associated with the
mucus layer, and also responded to secretagogue
stimulation. All these data strongly suggest that
TFF peptides are implicated in the function of the
mucus produced by colon carcinoma cells.
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